Success stories
US govt contract for SA medical isotopes
Move away from highly enriched uranium
The award, from the US Department of Energy's National Nuclear Security Administration (NNSA), comes amid an international shortage of molybdenum-99 (Mo-99), as well as US-led drive to minimize the use of highly enriched uranium, which can be used in nuclear weapons. "NNSA's Global Threat Reduction Initiative works with our partners around the world to minimise the use of highly enriched uranium in civilian nuclear applications," the NNSA's Ken Baker said in a statement last week. Molybdenum-99 is a radio isotope produced during nuclear fission. Its "daughter radio isotope", technetium-99m, is used in numerous medical procedures.World's leading producer of medical radio isotopes
Business Day writer Tamar Kahn said this week that the deal would give impetus to Necsa's shift to industrial applications of low-enriched uranium. CEO Rob Adam told Business Day that Necsa was already the world's leading producer of medical radio isotopes, exporting to 55 countries. Necsa's Safari reactor is the world's biggest producer of Mo-99, Adam said, although most of it is still derived from high-enriched uranium, while that derived from low-enriched uranium was currently about 20% more expensive to produce. The contract would enable Necsa, in partnership with Ansto, to improve the technology and lower costs, Adam told Business Day. SAinfo reporter
Would you like to use this article in your publication or on your website? See: Using SAinfo material
